Ampliva Biotechnologies is a microbiology research and diagnostics company dedicated to developing innovative tools and technologies that address critical gaps in infectious disease detection and antimicrobial resistance (AMR). We conduct applied research at the intersection of molecular biology, point-of-care diagnostics, and microbial science, translating laboratory discoveries into real-world solutions that save lives and combat one of the greatest threats to global health.

Most diagnostic tools today require centralized lab infrastructure, specialized training, and long turnaround times. We're changing that. Ampliva develops accessible, rapid testing technologies designed to work at the point of care — putting actionable results directly in the hands of clinicians and researchers when and where they're needed most. Our mission-driven approach combines deep molecular biology expertise with a focus on making advanced diagnostics available to healthcare providers and institutions worldwide, including those in under-resourced settings.